Publications by authors named "Agnes Ernst"

Article Synopsis
  • A new systems biology approach was created to compare brain tissue from both rodent models of schizophrenia and human patients to identify which model best reflects the human disease.
  • Researchers used LC-MS proteomic profiling to analyze differences in protein abundance in brain tissues, finding significant changes that relate to five functional domains of schizophrenia across all rodent models studied.
  • The study determined that the chronic PCP rodent model most closely matches human schizophrenia brain changes, potentially helping improve drug discovery and understanding of the disease's biology.
View Article and Find Full Text PDF

Current schizophrenia (SCZ) treatments fail to treat the broad range of manifestations associated with this devastating disorder. Thus, new translational models that reproduce the core pathological features are urgently needed to facilitate novel drug discovery efforts. Here, we report findings from the first comprehensive label-free liquid-mass spectrometry proteomic- and proton nuclear magnetic resonance-based metabonomic profiling of the rat frontal cortex after chronic phencyclidine (PCP) intervention, which induces SCZ-like symptoms.

View Article and Find Full Text PDF

Administration of the noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist phencyclidine (PCP) to rodents is widely used as preclinical model for schizophrenia. Most studies on this model employ methods investigating behavior and brain abnormalities. However, little is known about the corresponding peripheral effects.

View Article and Find Full Text PDF

Background: Establishing preclinical models is essential for novel drug discovery in schizophrenia. Most existing models are characterized by abnormalities in behavioral readouts, which are informative, but do not necessarily translate to the symptoms of the human disease. Therefore, there is a necessity of characterizing the preclinical models from a molecular point of view.

View Article and Find Full Text PDF

Modeling neuropsychiatric disorders in animals poses a significant challenge due to the subjective nature of diverse often overlapping symptoms, lack of objective biomarkers and diagnostics, and the rudimentary understanding of the pathophysiology. Successful translational research requires animal models that can inform about disease mechanisms and therapeutic targets. Here, we review behavioral and neurobiological findings from selected animal models, based on presumed etiology and risk factors, for schizophrenia, bipolar disorder, and major depressive disorder.

View Article and Find Full Text PDF